Updates in hormonal emergency contraception

Pharmacotherapy

Volumn 31, Issue 9, 2011, Pages 887-895

  Shrader, Sarah P ^a   Hall, Larissa N ^b   Ragucci, Kelly R ^a   Rafie, Sally ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Ella; Emergency contraception; Hormonal contraception; Levonorgestrel; Plan B; Ulipristal

Indexed keywords

BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; ESTROGEN; GESTAGEN; HYPERICUM PERFORATUM EXTRACT; LEVONORGESTREL; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENYTOIN; PROGESTERONE; PROGESTERONE RECEPTOR; RIFAMPICIN; TOPIRAMATE; ULIPRISTAL;

ABDOMINAL PAIN; ABORTION; AGE; BLEEDING; BREAKTHROUGH BLEEDING; BREAST TENDERNESS; CARDIOVASCULAR DISEASE; DELAYED OVULATION; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; ECTOPIC PREGNANCY; EMERGENCY CONTRACEPTION; HORMONAL CONTRACEPTION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUATION; NAUSEA; NAUSEA AND VOMITING; OVULATION; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACIST; PREGNANCY; PREGNANCY RATE; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; PROFESSIONAL PRACTICE; REPEATED DRUG DOSE; REVIEW; SEXUAL INTERCOURSE; SINGLE DRUG DOSE; SPOTTING; THROMBOEMBOLISM;

CONTRACEPTIVES, POSTCOITAL; HUMANS; LEVONORGESTREL; NORPREGNADIENES; PATIENT EDUCATION AS TOPIC; UNSAFE SEX;

EID: 80052246556     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.31.9.887     Document Type: Review

References (57)

1. Department of Health and Human Services. United States code of federal regulations: protection of human subjects. Title 45, CFR 46.202, effective July 14, 2009. Available from http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46. html. Accessed April 7, 2011.
2. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation: effects on the probability of conception, survival of the pregnancy and sex of the baby. N Engl J Med 1995;333:517-21.
3. Wilcox AJ, Dunson D, Baird DD. The timing of the "fertile window" in the menstrual cycle: day specific estimates from a prospective study. BMJ 2000;321:1259-62.
4. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24-9, 46.
5. Frost JJ, Singh S, Finer B. U.S. women's one-year contraceptive use patterns, 2004. Perspect Sex Reprod Health 2007;39:48-55.
6. Trussell J. Contraceptive failure in the United States. Contraception 2004;70:89-96. (Pubitemid 38993483)
7. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-6.
8. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998;352:428-33.
9. von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360:1803-10. (Pubitemid 35449417)
10. Jones R, Darroch J, Henshaw S. Contraceptive use among U.S. women having abortions, 2000-2001. Perspect Sex Reprod Health 2002;34:294-303.
11. Kaiser Family Foundation. Women's health care providers experiences with emergency contraception, 2003. Available from www.kff.org/womenshealth/3343- index.cfm. Accessed November 12, 2010.
12. Stewart F, Trussell J, Van Look PFA. Emergency contraception. In: Hatcher RA, Trusell J, Nelson AL, Cates W Jr, Stewart F, Kowal D, eds. Contraceptive technology, 19th ed. New York, NY: Ardent Media, 2007:97-116.
13. Durand M, del Carmen Cravioto M, Raymond EG, et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception 2001;64:227-34. (Pubitemid 34020817)
14. Croxatto HB, Devoto L, Durand M, et al. Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraception 2001;63:111-21. (Pubitemid 32451802)
15. Marions L, Hultenby K, Lindell I, Sun X, Stabi B, Gemzell Danielsson K. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol 2002;100:65-71. (Pubitemid 34722844)
16. Marions L, Cekan SZ, Bygdeman M, Gemzell Danielsson K. Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function. Contraception 2004;69:373-7. (Pubitemid 38510327)
17. Noe G, Croxatto HB, Salvaiterra AM, et al. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception 2010;81:414-20.
18. Kubba AA, White JO, Guillebaud J, Elder MG. The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinyl estradiol combination or danazol. Fertil Steril 1986;45:512-16. (Pubitemid 16120651)
19. Ling WY, Wrixon W, Zayid I, Acorn T, Popat R, Wilson E. Mode of action of dl-norgestrel and ethinyl estradiol combination in postcoital contraception. Fertil Steril 1983;39:292-7.
20. Yound DC, Wiehle RD, Joshi SG, Poindexter AN III. Emergency contraception alters progesterone-associated endometrial protein in serum and uterine luminal fluid. Obstet Gynecol 1994;84:266-71. (Pubitemid 24234841)
21. Raymond EG, Lovely LP, Chen-Mok M, Seppala M, Kurman RJ, Lessey BA. Effect of Yuzpe regimen of emergency contraception on markers of endometrial receptivity. Hum Reprod 2000;15:2351-5.
22. Conard LA, Gold MA. Emergency contraceptive pills: a review of the recent literature. Curr Opin Obstet Gynecol 2004;16:389-95. (Pubitemid 41007540)
23. Arowojolu AO, Okewole IA, Adeknule AO. Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians Contraception 2002;66:269-73. (Erratum in Contraception 2003;67:165.)
24. Ngai SW, Fan S, Li S, et al. A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception. Hum Reprod 2005;20:307-11.
25. American College of Obstetricians and Gynecologists. Emergency contraception: practice bulletin no. 112. Obstet Gynecol 2010;115:1100-9.
26. Planned Parenthood. Morning-after pill (emergency contraception). Available from http://www.plannedparenthood.org/health-topics/emergency- contraception-morning-after-pill-4363.asp. Accessed June 16, 2011.
27. World Health Organization. Emergency contraception. Available from http://www.who.int/mediacentre/factsheets/fs244/en/index.html. Accessed June 30, 2011.
28. International Consortium for Emergency Contraception. Regimen update dosing and timing. Available from http://www.emergencycontraception.org/ publications/PDFs/policy/Dosage-Timing-English.pdf. Accessed June 16, 2011.
29. Raymond EG, Trussell J, Polis C. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol 2007;109:181-8. (Pubitemid 46035523)
30. Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA. Advance provision of emergency contraception for pregnancy prevention. Cochrane Database Syst Rev 2007(2):CD005497.
31. Drugstore.com. Plan B One-Step. Available from www.drugstore.com. Accessed October 10, 2010.
32. Duramed Pharmaceuticals, Inc. Plan B One-Step (levonorgestrel) package insert. Pomona, NY; 2009.
33. U.S. Food and Drug Administration. Recalls, market withdrawals, and safety alerts. Available from www.fda.gov. Accessed October 13, 2010.
34. Watson Pharma, Inc. Ella (ulipristal) package insert. Morristown, NJ; 2010.
35. Brache V, Cochon L, Jesam C, et al. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod 2010;25:2256-63.
36. Gemzell-Danielsson K. Mechanism of action of emergency contraception. Contraception 2010;82:404-9.
37. Paul F, Mathe H, Ginde S, Cullins V, Morfesis J, Gainer E. Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstet Gynecol 2010:115:257-63.
38. Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized non-inferiority trial and meta-analysis. Lancet 2010;375:555-62.
39. Creinin MD, Schlaff W, Archer DF, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006;108:1089-97. (Pubitemid 44665402)
40. Ahern R, Frattarelli LA, Delto J, Kaneshiro B. Knowledge and awareness of emergency contraception in adolescents. J Pediatr Adolesc Gynecol 2010;23:273-8.
41. Foster DG, Ralph LJ, Arons A, Brindis CD, Harper CC. Trends in knowledge of emergency contraception among women in California, 1999-2004. Womens Health Issues 2007;17:22-8.
42. National Campaign to Prevent Teen and Unplanned Pregnancy. Providers' perspectives: perceived barriers to contraceptive use in youth and young adults. Available from http://www.arhp.org/publications-and-resources/studies- andsurveys/providers-prospectives-perceived-barriers-to-contraceptive-use-in- youth-and-young-adults. Accessed April 8, 2011.
43. Farris KB, Ashwood D, McIntosh J, et al. Preventing unintended pregnancy: pharmacists' roles in practice and policy via partnerships. J Am Pharm Assoc 2010;50:604-12.
44. Gardner JS, Miller L, Downing DF, Le S, Blough B, Shotorbani S. Pharmacist prescribing of hormonal contraceptives: results of the direct access study. J Am Pharm Assoc 2008;48:212-21.
45. Maderas NJM, Landau SC. Pharmacy and clinic partnerships to expand access to injectable contraception. J Am Pharm Assoc 2007;47:527-31.
46. Shrader S, Rodden A, Carroll L, Peterson L. Knowledge and attitudes about emergency contraception among pharmacists and physician preceptors in South Carolina. Open Access J Contracept 2010;1:73-8.
47. Kelly PJ, Sable MR, Schwartz LR, Lisbon E, Hall MA. Physicians' intention to educate about emergency contraception. Fam Med 2008;40:40-5.
48. Jackson RA, Schwarz EB, Freedman L, Darney P. Advance supply of emergency contraception. Effect on use and usual contraception - a randomized trial. Obstet Gynecol 2003;102:8-16.
49. Lo SS, Fan SY, Ho PC, Glasier AF. Effect of advanced provision of emergency contraception on women's contraceptive behaviour: a randomized controlled trial. Hum Reprod 2004;19:2404-10. (Pubitemid 39406708)
50. Raine T, Harper C, Rocca CH, et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA 2005;293:54-62. (Pubitemid 40066699)
51. French AC, Kaunitz AM. Pharmacy access to emergency hormonal contraception in Jacksonville, FL: a secret shopper survey. Contraception. 2007;75:126-30. (Pubitemid 46108725)
52. Borrego ME, Short J, House N, Gupchup G, Naik R, Cuellar D. New Mexico's pharmacists' knowledge, attitudes, and beliefs toward prescribing oral emergency contraception. J Am Pharm Assoc 2006;46:33-43. (Pubitemid 46037383)
53. Bennett W, Petraitis C, D'Anella A, Marcella S. Pharmacists' knowledge and the difficulty of obtaining emergency contraception. Contraception 2003;68:261-7. (Pubitemid 37311365)
54. Wallace JL, Wu J, Weinstein J, Gorenflo DW, Fetters MD. Emergency contraception: knowledge and attitudes of family medicine providers. Fam Med 2004;36:417-22. (Pubitemid 38720584)
55. El-Ibiary SY, Raine T, McIntosh J, Darney PD, Harper CC. Pharmacy access to emergency contraception: perspectives of pharmacists at a chain pharmacy in San Francisco. J Am Pharm Assoc 2007;47:702-10.
56. Nelson AL, Jaime CM. Accuracy of information given by Los Angeles County pharmacies about emergency contraceptives to sham-patient in need. Contraception 2009;79:206-10.
57. American College of Clinical Pharmacy. ACCP position statement: prerogative of a pharmacist to decline to provide professional services based on conscience. Adopted by ACCP Board of Regents on August 2005. Available from http://www.accp.com/docs/positions/positionStatements/pos31-200508.pdf. Accessed October 13, 2010.